Proinflammatory effects of IL-10 during human endotoxemia.
about
Regulation of adaptive immunity; the role of interleukin-10Interleukin-10: new perspectives on an old cytokineIs boosting the immune system in sepsis appropriate?Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia StudyTreatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gammaDiet-Induced Obesity Is Associated with an Impaired NK Cell Function and an Increased Colon Cancer IncidenceEstradiol Priming Improves Gonadotrope Sensitivity and Pro-Inflammatory Cytokines in Obese Women.Safety, Antitumor Activity, and Immune Activation of Pegylated Recombinant Human Interleukin-10 (AM0010) in Patients With Advanced Solid Tumors.Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin.Of microbes and meals: the health consequences of dietary endotoxemia.In vitro and in vivo targeted delivery of IL-10 interfering RNA by JC virus-like particles.The chemokine CCL2 is required for control of murine gastric Salmonella enterica infectionCellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum.Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes.Role of tumor necrosis factor alpha (TNF-alpha) and interleukin-10 in the pathogenesis of severe murine monocytotropic ehrlichiosis: increased resistance of TNF receptor p55- and p75-deficient mice to fatal ehrlichial infection.Infection of human dendritic cells with a Mycobacterium tuberculosis sigE mutant stimulates production of high levels of interleukin-10 but low levels of CXCL10: impact on the T-cell responseImmune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetesSecretory expression of biologically active human Herpes virus interleukin-10 analogues in Escherichia coli via a modified Sec-dependent transporter constructMore than skin deep: functional genomic basis for resistance to amphibian chytridiomycosis.Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.Gut dendritic cell activation links an altered colonic microbiome to mucosal and systemic T-cell activation in untreated HIV-1 infectionDifferences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion.Non-Steroid Anti-Inflammatory Drugs Are Better than Acetaminophen on Fever Control at Acute Stage of FractureThe molecular basis of IL-10 function: from receptor structure to the onset of signaling.Immunotherapy with IL-10- and IFN-γ-producing CD4 effector cells modulate "Natural" and "Inducible" CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer.Contribution of Reduced Interleukin-10 Levels to the Pathogenesis of Osteomyelitis in Children with Sickle Cell Disease.Salmonella Typhimurium exploits inflammation to its own advantage in piglets.Maternal supplementation of seaweed-derived polysaccharides improves intestinal health and immune status of suckling pigletsIL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration.Interleukin-10 and the immune response against cancer: a counterpoint.Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants.TLR9 in health and disease.Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy.Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flowIL-10-Induced miR-155 Targets SOCS1 To Enhance IgE-Mediated Mast Cell FunctionFrom therapy to experimental model: a hundred years of endotoxin administration to human subjects.Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms.PEG-rIL-10 treatment decreases FoxP3(+) Tregs despite upregulation of intratumoral IDOCross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.
P2860
Q21131215-73065D92-CAD4-4C56-8375-CA145D58AB4BQ24653771-6AEFE371-E93F-4F09-BF01-FB9A998DDFD5Q27691996-D08362BA-B8E6-44E1-857F-199F8706512EQ28168368-8DAA22B8-5954-4B51-BCD5-980773FCFF5FQ28344937-19D318D9-4B3B-4F40-A19D-4097A76C9E4BQ30313294-5D3B63FE-BF6D-4FFF-8D57-E4B0DAE29490Q30355579-4398A1AD-4050-4CDE-BBEB-9309BD3DB398Q33434666-2F51F464-7008-453C-8569-708913D27A37Q33641150-026D39BD-9F92-4FEF-AE1A-F15A643E89A8Q33713662-8F6506E4-1505-45B6-B961-2F457C065907Q33986471-DC91BEAA-3E6A-4E91-A34F-80C1E21049F4Q34033543-B64077F1-7EF0-4472-9833-5012A31AFEEDQ34125424-6F8DE1F4-4C37-48C6-881C-2CA235057DABQ34486748-35282B27-E613-4147-8421-0939841D5A4CQ34491804-8518BC45-E647-4DC3-AC9E-7F59ABE14721Q34681342-F5F823D9-072F-4AB5-9B32-979B05F35A24Q34987849-8A6DE336-D189-49D0-9BB4-FA0B59C147FBQ35007984-3DE7B232-C1B8-41CA-AA9C-6FAE6F21352AQ35047570-647B6CA6-4E97-4FA3-8FCC-7A476D68018BQ35541507-85F5667A-E866-4E8A-9E44-4DD7F2A1B42FQ35617066-E25CED06-C4E0-45F3-A9FD-29868902AF4AQ35648006-C267B726-2878-46A5-9038-44F5F0D69FD6Q35796961-5BD25D78-8EF3-4BD7-B67A-B9D417B2995FQ35810601-D08B11CD-1009-43A1-9473-9154BFF3F8B4Q35861249-E6CFDA29-5AD3-4489-B459-C2AA0D691120Q35998763-EDADC0ED-D549-43C2-9D2B-0A64971223C1Q36097774-10A03B5A-774C-46A1-84E8-AAAF6F120B14Q36177673-01B9A4EB-135F-48B3-BB0B-096340DDA2F0Q36252477-FBB0B59B-ED5F-41A8-A4A8-A446EC0FDDD7Q36276594-11129661-3E3D-42EE-90A2-D66EE41E50AEQ36439020-67C362C9-11F2-41F0-ADCA-3BC33A2678BDQ36526346-7E6C90E8-F78C-4BA4-84EE-AB191A379A0FQ36715205-DA9E6EF5-2EE6-48BA-8C86-FDA004CF6586Q36902534-DEAF0272-0564-4C00-BC6C-61ED465EC917Q36923849-876C7FAA-A13D-4EDF-B08D-82D713D160D0Q36994694-B41CAB85-6BBD-4634-B01C-C103FDC9E110Q37071983-61466C3E-6421-47B4-B456-8CEF914F87AEQ37222162-A723AA14-9272-4892-8ED0-2D0C8F4853CCQ37414046-012C9665-DC1E-4775-B217-2CE46CBADF58Q37544674-6C1EDFD7-2234-4852-BF91-9AB38A9CDB2E
P2860
Proinflammatory effects of IL-10 during human endotoxemia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Proinflammatory effects of IL-10 during human endotoxemia.
@ast
Proinflammatory effects of IL-10 during human endotoxemia.
@en
type
label
Proinflammatory effects of IL-10 during human endotoxemia.
@ast
Proinflammatory effects of IL-10 during human endotoxemia.
@en
prefLabel
Proinflammatory effects of IL-10 during human endotoxemia.
@ast
Proinflammatory effects of IL-10 during human endotoxemia.
@en
P2093
P1476
Proinflammatory effects of IL-10 during human endotoxemia.
@en
P2093
Kurimoto M
van Deventer SJ
van der Poll T
P304
P356
10.4049/JIMMUNOL.165.5.2783
P407
P577
2000-09-01T00:00:00Z